EPO, an important drug for treating anemia, can now be produced in higher quantities and with better quality in mammalian cells designed using CRISPR.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/02/200219113740.htm
No comments:
Post a Comment